NCT04550780View on ClinicalTrials.gov

Nation-wide Health Resource Consumption and Costs Associated With Mepolizumab

CompletedOBSERVATIONAL
Enrollment

7,938

Participants

Timeline

Start Date

December 3, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Asthma
Interventions
DRUG

Mepolizumab

The first administration of mepolizumab.

Trial Locations (1)

34280

Uh Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04550780 - Nation-wide Health Resource Consumption and Costs Associated With Mepolizumab | Biotech Hunter | Biotech Hunter